The lupus research team is led by Professor Fabienne Mackay
and is dedicated to the development of new therapies to treat lupus.
Professor Mackay's work has been instrumental in the development of a
new treatment called belimumab. This is the first new treatment for
lupus in over 50 years. While this is an advance in medicine it is only
effective in a subset of patients. There is still a large number of
patients awaiting an effective treatment. The team includes Dr Fabien Vincent, a rheumatologist whose research is aimed at understanding why lupus develops differently in different groups of people.
Direct link to Lupus donation page.